Expression and biological-clinical significance of hTR, hTERT and CKS2 in washing fluids of patients with bladder cancer

BMC Urology

Volumn 10, Issue , 2010, Pages

  Mezzasoma, Letizia ^a   Antognelli, Cinzia ^a   Del Buono, Chiara ^a   Stracci, Fabrizio ^a   Cottini, Emanuele ^a   Cochetti, Giovanni ^a   Talesa, Vincenzo N ^a   Mearini, Ettore ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 2; MOLECULAR MARKER; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; CARRIER PROTEIN; CELL CYCLE PROTEIN; CKS2 PROTEIN, HUMAN; HTR RNA; PEPTIDE FRAGMENT; PROTEIN KINASE; TELOMERASE REVERSE TRANSCRIPTASE (540 548); TELOMERASE REVERSE TRANSCRIPTASE (540-548); UNTRANSLATED RNA;

ADULT; AGED; ARTICLE; BLADDER CANCER; BLADDER CARCINOGENESIS; BLADDER IRRIGATION; CANCER DIAGNOSIS; CANCER GROWTH; CONTROLLED STUDY; DNA SYNTHESIS; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; MALE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; BLADDER; BLADDER TUMOR; CANCER INVASION; DISCRIMINANT ANALYSIS; DISEASE COURSE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS; LAVAGE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; RECEIVER OPERATING CHARACTERISTIC; STATISTICAL MODEL;

AGED; AGED, 80 AND OVER; CARRIER PROTEINS; CELL CYCLE PROTEINS; DISCRIMINANT ANALYSIS; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PEPTIDE FRAGMENTS; PROTEIN KINASES; RNA, UNTRANSLATED; ROC CURVE; TELOMERASE; THERAPEUTIC IRRIGATION; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 77957272055     PISSN: 14712490     EISSN: 14712490     Source Type: Journal    
DOI: 10.1186/1471-2490-10-17     Document Type: Article

References (43)

1. Bladder cancer: epidemiology, staging and grading, and diagnosis. Z Kirkali T Chan M Manoharan F Algaba C Busch L Cheng L Kiemeney M Kriegmair R Montironi WM Murphy IA Sesterhenn M Tachibana J Weider, Urology 2005 66 Supp 1 4 34 10.1016/j.urology.2005.07.062 16399414
2. Molecular pathogenesis of bladder cancer. MA Knowles, Int J Clin Oncol 2008 13 287 297 10.1007/s10147-008-0812-0 18704628
3. Telomeres and telomerase: their mechanisms of action and effects of altering their functions. EH Blackburn, FEBS Lett 2005 579 859 862 10.1016/j.febslet.2004.11.036 15680963
4. Telomerase redefined: Integrated regulation of hTR and hTERT for telomere maintenance and telomerase activity. CJ Cairney WN Keth, Biochimie 2008 90 13 23 10.1016/j.biochi.2007.07.025 17854971
5. Telomeres and telomerase in cancer. SE Artandi RA DePinho, Carcinogenesis 2010 31 9 18 10.1093/carcin/bgp268 19887512
6. Role of telomeres and telomerase in the pathogenesis of human cancer. WC Hahn, J Clin Oncol 2003 21 2034 2043 10.1200/JCO.2003.06.018 12743159
7. Transformation of normal human cells in the absence of telomerase activation. YR Seger M García-Cao S Piccinin C Lo Cunsolo C Doglioni MA Blasco GJ Hannon R Maestro, Cancer Cell 2002 2 410 413 10.1016/S1535-6108(02) 00183-6 (Pubitemid 41039106)
8. Telomerase and cancer. EH Blackburn, Mol Cancer Res 2005 3 Suppl 9 477 482 10.1158/1541-7786.MCR-05-0147 16179494
9. Evolving views of telomerase and cancer. M Blasco WC Hahn, Trends Cell Biol 2003 13 289 294 10.1016/S0962-8924(03)00085-0 12791294
10. Cyclin-dependent kinase-associated proteins Cks1 and Cks2 are essential during early embryogenesis and for cell cycle progression in somatic cells. HS Martinsson-Ahlzén V Liberal B Grünenfelder SR Chaves CH Spruck SI Reed, Mol Cell Biol 2008 18 5698 5709 10.1128/MCB.01833-07
11. Requirement of Cks2 for the first metaphase/anaphase transition of mammalian meiosis. CH Spruck MP De Miguel AP Smith A Ryan P Stein RM Schultz AJ Lincoln PJ Donovan SI Reed, Science 2003 300 647 650 10.1126/science.1084149 12714746
12. Microarray gene expression profiling in meningiomas: differential expression according to grade or histopathological subtype. M Fèvre-Montange J Champier A Durand A Wierinckx J Honnorat J Guyotat A Jouvet, Int J Oncol 2009 35 1395 1407 10.3892/ijo-00000457 19885562
13. Aberrant expression of Cks1 and Cks2 contributes to prostate tumorigenesis by promoting proliferation and inhibiting programmed cell death. Y Lan Y Zhang J Wang C Lin MM Ittmann F Wang, Int J Cancer 2008 123 543 551 10.1002/ijc.23548 18498131
14. Genome-wide gene expression profiling of cervical cancer in Hong Kong women by oligonucleotide microarray. YF Wong TH Cheung GS Tsao KW Lo SF Yim VW Wang MM Heung SC Chan LK Chan TW Ho KW Wong C Li Y Guo TK Chung DI Smith, Int J Cancer 2006 118 2461 2469 10.1002/ijc.21660 16353136
15. Upregulation of the cycline kinase subunit Cks2 increases cell proliferation rate in gastric cancer. MA Kang JT Kim JH Kim SY Kim YH Kim YI Yeom Y Lee HG Lee, J Cancer Res Clin Oncol 2009 135 761 769 10.1007/s00432-008- 0510-3 19034516
16. Genes associated with liver metastasis of colon cancer, identified by genome-wide cDNA microarray. M Li YM Lin S Hasegawa T Shimokawa K Murata M Kameyama O Ishikawa T Katagiri T Tsunoda Y Nakamura Y Furukawa, Int J Oncol 2004 24 305 312 14719106
17. Telomerase and other novel approaches to bladder cancer detection. A Bennett, Clin Lab Sci 2008 21 185 190 18678141
18. Relevance of urine telomerase in diagnosis of bladder cancer. MA Sanchini R Gunelli O Nanni S Bravaccini C Fabbri A Sermasi E Bercovich A Ravaioli D Amadori D Calistri, JAMA 2005 294 2052 2056 10.1001/jama.294.16.2052 16249419
19. Telomerase: Its clinical relevance in the diagnosis of bladder cancer. M Muller, Oncogene 2002 21 650 655 10.1038/sj.onc.1205071 11850792
20. Telomerase: a potential marker of bladder transitional cell carcinoma in bladder washes. DH Lee SC Yang SJ Hong BH Chung IY Kim, Clin Cancer Res 1998 4 535 438 9533519
21. Urine telomerase activity for the detection of bladder cancer in females. S Bravaccini MA Sanchini AM Granato R Gunelli O Nanni D Amadori D Calistri R Silvestrini, J Urol 2007 178 57 61 10.1016/j.juro.2007.03.025 17574060
22. Real-time quantitative analysis for human telomerase reverse transcriptase mRNA and human telomerase RNA component mRNA expressions as markers for clinicopathologic parameters in urinary bladder cancer. Y Takihana T Tsuchida M Fukasawa I Araki N Tanabe M Takeda, Int J Urol 2006 13 401 408 10.1111/j.1442-2042.2006.01300.x 16734859
23. Quantitative evaluation of telomerase subunits in urine as biomarkers for non invasive detection of bladder cancer. S Weikert H Krause I Wolff F Christoph M Schrader T Emrich K Miller M Muller, Int J Cancer 2005 117 274 280 10.1002/ijc.21168 15900578
24. A prospective evaluation of the diagnostic and potential prognostic utility of urinary human telomerase reverse transcriptase mRNA in patients with bladder cancer. L Bowles H Bialkowska-Hobrzanska B Bukala L Nott H Razvi, Can J Urol 2004 11 2438 2444 15636669
25. Identification of differentially expressed genes in human bladder cancer through genome-wide gene expression profiling. K Kawakami H Enokida T Tachiwada T Gotanda K Tsuneyoshi H Kubo K Nishiyama M Takiguchi M Nakagawa N Seki, Oncol Rep 2006 16 521 531 16865252
26. Detection of the presence of catalytic subunit mRNA associated with telomerase gene in exfoliated urothelial cells from patients with bladder cancer. K Isurugi Y Suzuki S Tanji T Fujioka, J Urol 2002 168 1574 1577 10.1016/S0022-5347(05)64523-5 12352460
27. Expression of the RNA component of human telomerase (hTR) in ThinPrep preparation from bladder washings. A Maitra A Rathi AF Gazdar A Sagalowsky R Ashfaq, Cancer 2001 93 73 79 10.1002/1097-0142(20010225)93:1<73::AID- CNCR9010>3.0.CO;2-I 11241269
28. Surveillance of patients with bladder carcinoma using fluorescent in-situ hybridization on bladder washings. J Bergman RC Reznichek J Rajfer, BJU Int 2008 101 26 29 17850364
29. Bladder wash cytology, quantitative cytology, and the qualitative BTA test in patients with superficial bladder cancer. HG Van der Poel MR Van Balken DH Schamhart P Peelen T de Reijke FM Debruyne JA Schalken JA Witjes, Urology 1998 51 44 50 10.1016/S0090-4295(97)00496-2 9457287
30. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. ER DeLong DM DeLong DL Clarke-Pearson, Biometrics 1988 44 837 845 10.2307/2531595 3203132
31. The meaning and use of the area under a receiver operating characteristic (ROC) curve. JA Hanley BJ McNeil, Radiology 1982 143 29 36 7063747
32. Involvement of NF-Y and Sp1 binding sequences in basal transcription of the human telomerase RNA gene. J Zhao A Bilsland SF Hoare WN Keith, FEBS Lett 2003 536 111 119 10.1016/S0014-5793(03)00038-3 12586348
33. MDM2 negatively regulates the human telomerase RNA gene promoter. J Zhao A Bilsland K Jackson WN Keith, BMC Cancer 2005 5 6 14 10.1186/1471-2407-5-6 15656906
34. Expression of Human Telomerase Subunits and Correlation with Telomerase Activity in Urothelial Cancer. H Ito S Kyo T Kanaya M Takakura M Inoue M Namiki, Clin Cancer Res 1998 4 1603 1608 9676833 (Pubitemid 28304720)
35. Real-Time quantification of human telomerase reverse transcriptase in tumors and healty tissue. JB De Kok JM Ruers GNP Van Muijen A VanBokhoven HL Willems DW Swinkels, Clin Chem 2000 46 313 318 10702516
36. Detection of human telomerase reverse transcriptase mRNA in urine of patients with bladder cancer: evaluation of an emerging tumor marker. N Melissourgos NG Kastrinakis I Davilas P Foukas A Farmakis M Lykourinas, Urology 2003 62 362 367 10.1016/S0090-4295(03)00254-1 12893365
37. Clinical evaluation of human telomerase catalytic subunit in bladder washings from patients with bladder cancer. T Fukui N Nonomura T Tokizane E Sato Y Ono Y Harada K Nishimura S Takahara A Okuyama, Mol Urol 2001 5 19 23 10.1089/109153601750124249 11689147
38. Quantification of hTERT mRNA and telomerase activity in bladder washings of patients with recurrent urothelial cell carcinomas. JB De Kok MR Van Balken RW Roelofs YA Van Aarssen DW Swinkels JM Klein Gunnewiek, Clin Chem 2000 46 2003 2007 11106338
39. Telomerase activity is associated with cell cycle deregulation in human breast cancer. G Landberg NH Nielsen P Nilsson SO Emdin J Cajander G Roos, Cancer Res 1997 57 549 554 9012489
40. Rb and EF-1 regulates telomerase activity in human cancer cells. DL Crowe DC Nguyen, Biochim Biophys Acta 2001 1518 1 6 11267653
41. Molecular markers in bladder cancer. SF Shariat JA Karam SP Lerner, Curr Opin Urol 2008 18 1 8 10.1097/MOU.0b013e3282f1c5c1 18090481
42. The human plasma proteome: history, character, and diagnostic prospects. NL Anderson NG Anderson, Mol Cell Proteom J 2002 1 845 867 10.1074/mcp.R200007- MCP200
43. Molecular markers for bladder cancer: the road to multimarker approach. M Birkhahn AP Mitra RJ Cote, Expert Rev Anticancer Ther 2007 7 1717 1727 10.1586/14737140.7.12.1717 18062746